525 related articles for article (PubMed ID: 26671446)
1. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
Wagner L; Klemann C; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jun; 184(3):265-83. PubMed ID: 26671446
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.
Qi SY; Riviere PJ; Trojnar J; Junien JL; Akinsanya KO
Biochem J; 2003 Jul; 373(Pt 1):179-89. PubMed ID: 12662155
[TBL] [Abstract][Full Text] [Related]
3. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
4. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
5. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer.
Kotacková L; Baláziová E; Sedo A
Folia Biol (Praha); 2009; 55(3):77-84. PubMed ID: 19545486
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
Chowdhury S; Chen Y; Yao TW; Ajami K; Wang XM; Popov Y; Schuppan D; Bertolino P; McCaughan GW; Yu DM; Gorrell MD
World J Gastroenterol; 2013 May; 19(19):2883-93. PubMed ID: 23704821
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer.
Busek P; Malík R; Sedo A
Int J Biochem Cell Biol; 2004 Mar; 36(3):408-21. PubMed ID: 14687920
[TBL] [Abstract][Full Text] [Related]
9. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8.
Abbott CA; Yu DM; Woollatt E; Sutherland GR; McCaughan GW; Gorrell MD
Eur J Biochem; 2000 Oct; 267(20):6140-50. PubMed ID: 11012666
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins.
Liu J; Huan Y; Li C; Liu M; Shen Z
Acta Pharm Sin B; 2014 Apr; 4(2):135-40. PubMed ID: 26579375
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme.
Matteucci E; Giampietro O
Curr Med Chem; 2009; 16(23):2943-51. PubMed ID: 19689275
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil?
Busek P; Stremenova J; Sedo A
Front Biosci; 2008 Jan; 13():2319-26. PubMed ID: 17981714
[TBL] [Abstract][Full Text] [Related]
14. Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.
Yazbeck R; Jaenisch SE; Abbott CA
Protoplasma; 2018 Jan; 255(1):375-386. PubMed ID: 28620698
[TBL] [Abstract][Full Text] [Related]
15. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.
Yao TW; Kim WS; Yu DM; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD
Mol Cancer Res; 2011 Jul; 9(7):948-59. PubMed ID: 21622624
[TBL] [Abstract][Full Text] [Related]
16. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
Huan Y; Jiang Q; Liu JL; Shen ZF
J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Yazbeck R; Howarth GS; Abbott CA
Trends Pharmacol Sci; 2009 Nov; 30(11):600-7. PubMed ID: 19837468
[TBL] [Abstract][Full Text] [Related]
19. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
Matheeussen V; Waumans Y; Martinet W; Van Goethem S; Van der Veken P; Scharpé S; Augustyns K; De Meyer GR; De Meester I
Basic Res Cardiol; 2013 May; 108(3):350. PubMed ID: 23608773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]